No Data
No Data
Fresenius Medical Care (FMS.US) will release its financial report on November 5th.
$Fresenius Medical Care (FMS.US)$ will release its financial report on November 5th, investors are welcome to pay attention. How was the previous performance? $Fresenius Medical Care (FMS.US)$ had revenue of 4.766 billion euros and net income of 0.241 billion euros in 2024/Q2, with earnings per share of 0.32 euros. In 2023/Q3, revenue was 4.936237 billion euros, net income was 0.147061 billion euros, and earnings per share was 0.145 euros. The above data is based on US GAAP accounting standards. Futubull tip: 1. The accounting year for Hong Kong and US listed companies is divided by time.
AlphaValue/Baader Europe Downgrades Fresenius Medical Care to Add, Lifts PT
Warburg Research Sticks to Their Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Should Value Investors Buy Fresenius Medical Care AG & Co. (FMS) Stock?
Sell Rating for Fresenius Medical Care Due to Weak Growth and Margin Pressures
Fresenius Medical Care Showcases Research and Innovations in Kidney Care at American Society of Nephrology (ASN) Kidney Week 2024
No Data
No Data